Commonwealth Equity Services’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,715
Closed -$203K 4301
2024
Q4
$203K Sell
4,715
-2,728
-37% -$117K ﹤0.01% 3747
2024
Q3
$330K Buy
7,443
+79
+1% +$3.5K ﹤0.01% 3273
2024
Q2
$293K Buy
7,364
+602
+9% +$24K ﹤0.01% 3314
2024
Q1
$292K Buy
6,762
+656
+11% +$28.3K ﹤0.01% 3302
2023
Q4
$254K Buy
6,106
+202
+3% +$8.4K ﹤0.01% 3317
2023
Q3
$235K Sell
5,904
-694
-11% -$27.6K ﹤0.01% 3241
2023
Q2
$270K Buy
6,598
+292
+5% +$11.9K ﹤0.01% 3139
2023
Q1
$258 Buy
6,306
+999
+19% +$41 ﹤0.01% 3090
2022
Q4
$217K Sell
5,307
-363
-6% -$14.8K ﹤0.01% 3151
2022
Q3
$227K Buy
5,670
+917
+19% +$36.7K ﹤0.01% 3064
2022
Q2
$199K Buy
4,753
+112
+2% +$4.69K ﹤0.01% 3207
2022
Q1
$210K Sell
4,641
-9,532
-67% -$431K ﹤0.01% 3292
2021
Q4
$654K Sell
14,173
-272
-2% -$12.6K ﹤0.01% 2303
2021
Q3
$685K Buy
14,445
+5
+0% +$237 ﹤0.01% 2232
2021
Q2
$747K Sell
14,440
-52
-0.4% -$2.69K ﹤0.01% 2146
2021
Q1
$729K Sell
14,492
-346
-2% -$17.4K ﹤0.01% 2039
2020
Q4
$772K Sell
14,838
-3,837
-21% -$200K ﹤0.01% 1831
2020
Q3
$812K Sell
18,675
-68,257
-79% -$2.97M ﹤0.01% 1621
2020
Q2
$3.74M Buy
+86,932
New +$3.74M 0.01% 714
2020
Q1
Sell
-5,141
Closed -$234K 2977
2019
Q4
$234K Sell
5,141
-23,268
-82% -$1.06M ﹤0.01% 2506
2019
Q3
$1.01M Sell
28,409
-1,274
-4% -$45.3K ﹤0.01% 1364
2019
Q2
$1.18M Sell
29,683
-1,276
-4% -$50.8K 0.01% 1251
2019
Q1
$1.29M Sell
30,959
-339
-1% -$14.1K 0.01% 1142
2018
Q4
$1.15M Sell
31,298
-85
-0.3% -$3.11K 0.01% 1127
2018
Q3
$1.52M Buy
31,383
+23,107
+279% +$1.12M 0.01% 1071
2018
Q2
$356K Sell
8,276
-1,912
-19% -$82.2K ﹤0.01% 1989
2018
Q1
$426K Sell
10,188
-1,939
-16% -$81.1K ﹤0.01% 1822
2017
Q4
$528K Sell
12,127
-1,505
-11% -$65.5K ﹤0.01% 1654
2017
Q3
$580K Buy
13,632
+190
+1% +$8.08K ﹤0.01% 1520
2017
Q2
$578K Sell
13,442
-26,894
-67% -$1.16M ﹤0.01% 1476
2017
Q1
$1.69M Buy
40,336
+27,548
+215% +$1.15M 0.01% 834
2016
Q4
$500K Sell
12,788
-865
-6% -$33.8K ﹤0.01% 1410
2016
Q3
$603K Buy
13,653
+10
+0.1% +$442 ﹤0.01% 1260
2016
Q2
$570K Sell
13,643
-80
-0.6% -$3.34K ﹤0.01% 1270
2016
Q1
$552K Sell
13,723
-399
-3% -$16.1K ﹤0.01% 1263
2015
Q4
$723K Sell
14,122
-1,153
-8% -$59K 0.01% 1096
2015
Q3
$717K Sell
15,275
-9,387
-38% -$441K 0.01% 1052
2015
Q2
$1.54M Buy
24,662
+236
+1% +$14.7K 0.02% 746
2015
Q1
$1.51M Buy
24,426
+9,496
+64% +$587K 0.02% 734
2014
Q4
$806K Sell
14,930
-5,812
-28% -$314K 0.01% 1009
2014
Q3
$1.1M Sell
20,742
-228
-1% -$12.1K 0.01% 824
2014
Q2
$1.09M Buy
20,970
+2,576
+14% +$134K 0.01% 818
2014
Q1
$861K Buy
18,394
+4,888
+36% +$229K 0.01% 882
2013
Q4
$594K Buy
13,506
+1,384
+11% +$60.9K 0.01% 1056
2013
Q3
$466K Buy
12,122
+4,024
+50% +$155K 0.01% 1125
2013
Q2
$285K Buy
+8,098
New +$285K 0.01% 1332